Cover Image
市場調查報告書

糖尿病護理市場的趨勢和機會

Trends and Opportunities in the Diabetes Care Market

出版商 Espicom Business Intelligence 商品編碼 293850
出版日期 內容資訊 英文 252 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
糖尿病護理市場的趨勢和機會 Trends and Opportunities in the Diabetes Care Market
出版日期: 2014年01月15日 內容資訊: 英文 252 Pages
簡介

2012年的全球糖尿病設備市值推算為122億美元。該市場由於激烈競爭、低醫療費給付水準及6家傳統龍頭製造商獨佔而縮小。各地區中,美國佔多數,歐洲以及其他已發展的市場緊追在後。可是,由於在這些地區不景氣和政府削減醫療費,結果經歷價格壓力及比通常遲緩的銷售額,新興國家、開發中國家中,SMBG(血糖自我監測)及手動胰島素給藥產品的需求變強。

本報告提供目前糖尿病設備市場相關資料總括性評論、市場領導企業、競爭產品及跨廣泛的技術領域的新發展等分析、糖尿病設備製造商名錄彙整,為您概述為以下內容。

摘要整理

市場概要

  • 背景
  • 全球糖尿病負擔
  • 糖尿病設備市場
  • 競爭環境
  • 促進成長要素、阻礙要素、未來的機會
  • 市場預測

糖尿病監測產品

  • 市場動態
  • 手動血糖自我監測產品
  • 其他的市場參與企業
  • 持續血糖檢測(CGM)
  • 非侵襲血糖檢測

胰島素給藥產品

  • 對應可能的患者人口
  • 市場趨勢
  • 未來市場預測
  • 手動胰島素注射產品
  • 胰島素幫浦
  • 替代胰島素給藥設備

整合型CGM胰島素幫浦系統

  • 現在可以利用的產品
  • 開發中的產品

人工胰技術

  • 半閉迴路方式
  • 研究開發

糖尿病設備廠商

  • 糖尿病設備企業的名錄

附錄

圖表清單

目錄
Product Code: RM228

This report provides everything you need to know about the current market for diabetes care devices; from detailed analysis of the products, companies and developments influencing its growth to an in-depth manufacturer directory detailing company movements within the market and key financial data (where available).

The global market for diabetes devices was estimated to be worth US$ 12.2 billion in 2012. And although this market was in decline due to intense competition and low reimbursement levels, as well as being traditionally dominated by 6 major manufacturers, good opportunities are growing more apparent for companies with unique diabetes devices or that compete in yet to be established markets.

In geographical terms, the US market dominates this sector, with Europe and other developed markets close behind. However, while these regions are experiencing pricing pressures and slower than usual sales volumes as a result of the economic downturn and government reductions in healthcare spending, there has been strong demand for SMBG (Self-monitoring blood glucose) and manual insulin delivery products in emerging and developing nations.

This new report from Espicom provides a complete and comprehensive review of the current diabetes device market, highlighting and analysing the market leaders, competing products and new developments across a wide range of technology areas. Furthermore, this report also acts as a diabetes device manufacturer directory detailing each company's recent key events in the diabetes sector and providing granular financial data (where available).

What this report contains:

  • Executive Summary
  • Market overview covering the global diabetes market, the competitive environment and the growth drivers, restraints and future opportunities
  • Market dynamics, detailed breakdown of key leading products, competing products and products in development for Diabetes Monitoring Products and Insulin Delivery Products
  • Current products and products in development within Combined CGM-Insulin Pump Systems technologies
  • Current research and development for Artificial Pancreas Technologies
  • Diabetes device company directory and company profiles for market-leading companies, detailing recent key events and important financial data

The Diabetes report is the foolproof business resource for any industry executive that needs to fully understand the current players and future prospects within the global diabetes market. The need for hard facts and statistics to back up everyday business decisions is essential and it is this report that can provide you with the answers.

Table of Contents

EXECUTIVE SUMMARY

MARKET OVERVIEW

  • BACKGROUND
    • Diagnosis and Management of Diabetes
      • Insulin-Dependent Diabetes Patients
      • Current Trends in Diabetes Care
  • THE GLOBAL BURDEN OF DIABETES
    • Diabetes Prevalence
      • Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group Study
    • Mortality
    • Diabetes Complications
    • The Cost of Diabetes
  • THE DIABETES DEVICE MARKET
    • Product Segments
    • Current Market Trends
    • Regional Perspective
  • COMPETITIVE ENVIRONMENT
    • New Market Entrants
    • Market Withdrawals
    • Rounding Out Product Portfolios
    • Market Consolidation
  • GROWTH DRIVERS, RESTRAINTS AND FUTURE OPPORTUNITIES
    • Regulatory and Reimbursement Environment
    • Connectivity and Data Integration
      • The Role of Telemonitoring in Diabetes Care
    • Emerging Technologies
      • New-Generation Insulin Delivery Devices
      • Development of a Closed-Loop System
      • Rival Technologies
        • Bariatric Surgery for Type 2 Diabetes
  • MARKET EXPECTATIONS

DIABETES MONITORING PRODUCTS

  • MARKET DYNAMICS
  • MANUAL SELF-MONITORING BLOOD GLUCOSE PRODUCTS
    • Current Market Environment
      • Regional Markets and Reimbursement
      • Accuracy Standards
        • GDH-PQQ Test Strips
      • New Product Developments
      • SMBG for Type 2 Diabetes Patients
      • Market Forecast
    • Competitive Environment
    • Market-Leading Self-Testing Blood Glucose Meters
      • Abbott's Blood Glucose Monitors
        • FreeStyle Blood Glucose Monitors and Test Strips
    • Arkray's Glucocard Products
    • Bayer's Blood Glucose Monitoring Systems
      • Contour Next Link
      • Contour Next and Contour Next USB
      • Contour USB
      • Contour, Contour TS, Contour Link and Breeze 2
    • LifeScan Products
      • Consumer Blood Glucose Monitoring Products
    • Nipro Diagnostics' TRUE Products
      • TRUE2go and TRUEresult
    • Roche Diabetes Care's Products
      • Blood Glucose Monitoring Products
      • Accu-Chek Aviva Expert
      • Accu-Chek FastClix Lancing Device
    • Other Market Participants
      • Product Highlights
        • ACON Laboratories' On Call Products
        • Bionime's BGMs
        • BodyTel Europe's GlucoTel
        • Cardiocom's Diabetes Management System
        • Decision Diagnostics'/Shasta Technologies' Genstrip Blood Glucose Test Strip
        • Entra Health Systems' MyGlucoHealth Network
        • IDEAL LIFE Gluco-Manager
        • Infopia's Blood Glucose Products
        • Max Medical's Minipro Self-Monitoring Blood Glucose System
        • Medisana's GlucoDock
        • Menarini's GlucoMen LX Plus/Glucofix Mio Plus
        • PositiveID/Smart Glucose Meter Corporation's iglucose
        • Sanofi's BGStar and iBGStar
        • Telcare's Telcare BGM
        • Ypsomed's mylife Unio
    • Products in Development
      • Intuity Medical's POGO Blood Glucose Monitoring System
      • National Diagnostic Products' BETACHEK C50 Cassette System
  • CONTINUOUS GLUCOSE MONITORING
    • The Benefits of CGM
    • Barriers to Adoption
      • The Cost of CGM
    • Clinical Trial Results - Highlighting Benefits and Drawbacks
    • The TD1 Exchange: User Experiences of CGM
    • CGM Market Trends and Opportunities
      • Regional Adoption Rates, Regulatory and Reimbursement Environment
        • United States
        • International Market
      • Future Prospects
    • Competitive Environment
    • Currently-Available Products
      • Medtronic's Guardian REAL-Time CGM System
      • Medtronic's Enlite CGM Sensor
      • DexCom's CGMs
        • SEVEN PLUS CGM System
        • DexCom G4 PLATINUM CGM
        • GlucoClear
      • Abbott's FreeStyle Navigator II
      • A Menarini Diagnostics' GlucoDay S
    • Products in Development
      • DexCom's Research and Development
        • DexCom Share System
        • Paediatric Use CGM in the US
        • Alliance with the Juvenile Diabetes Research Foundation
    • Roche's CGM System
    • New-Generation Implantable CGM Sensors
      • BioTex' Implantable CGM
      • EyeSense's FiberSense System
      • GlySens' ICGM
      • PositiveID & RECEPTORS' GlucoChip
      • Senseonics' CGM System
    • Minimally-Invasive CGM in Development
      • Echo Therapeutics' Symphony tCGM System
      • North Carolina State University, Sandia National Laboratories and University of California, San Diego's Microneedle Sensors
      • Sysmex' Minimally-Invasive ISF Extraction Technology (MIET)
  • NON-INVASIVE GLUCOSE MONITORING
    • Competitive Environment
    • AIMEDICS' HypoMon
    • Biosign Technologies' UFIT TEN-20 Non-Invasive Blood Pressure and Glucose Meter
    • Biovotion's Multisensor Glucose Monitoring System
    • Integrity Applications' GlucoTrack DF-F
    • Optical Technologies
      • EyeSense's Optical Sensor
      • Freedom Meditech's I-SugarX Glucose Monitoring System
      • Grove Instruments' Grove Glucometer
      • Lein Applied Diagnostics
      • LighTouch Medical's Non-Invasive Glucose Monitor
      • Massachusetts Institute of Technology's Raman Spectroscopy System
      • OrSense's NBM-200G Non-Invasive Blood Glucose Meter
      • St Louis Medical Devices Near-Infrared Light-Based System
      • Smart Tattoos
        • BioTex' Smart Tattoo
        • Charles Stark Draper Laboratory
        • Massachusetts Institute of Technology's Smart Tattoo
        • University of Strathclyde and King's College London
    • Tear Fluid Glucose Sensors
      • Mayo Clinic, Arizona State University and BioAccel
      • University of Washington and Microsoft Research
      • The University of Western Ontario's Glucose Monitoring Contact Lenses
    • Breath-Based Glucose Monitoring
      • PositiveID's EasyChek
      • Xhale's Breath-Based Glucose Monitor
      • Brown University and Saliva-Based Glucose Testing

INSULIN DELIVERY PRODUCTS

  • ADDRESSABLE PATIENT POPULATION
  • MARKET TRENDS
    • Competitive Environment
  • FUTURE MARKET PROSPECTS
  • MANUAL INSULIN INJECTION PRODUCTS
    • Insulin Pens
      • Competitive and Market Environment
      • Currently-Available Products
        • Biocon's INSUPen
        • Eli Lilly's HumaPen, Memoir and KwikPen Products
        • Owen Mumford's Autopen
        • Novo Nordisk's Products
        • Sanofi's AllSTAR, SoloSTAR and ClikSTAR
        • Ypsomed Delivery Systems
        • Ypsomed and Tonghua Dongbao Pharmaceutical's Sulin and Gansulin Pens
    • Needles and Syringes
      • Pen Needles
      • BD Diabetes Care Products
  • INSULIN PUMPS
    • The TD1 Exchange: User Experiences of Insulin Pumps
    • Current Market Trends
      • Regional Perspective
        • User Adoption Rates
        • Cost and Reimbursement
      • Regulatory Environment - FDA Infusion Pump Improvement Initiative
        • The Potential for Cyber Attacks
        • Competitive Environment
        • Market Outlook
    • Currently-Available Insulin Pumps
      • Animas Insulin Pumps
        • Animas Vibe
        • OneTouch Ping Glucose Management System
      • Asante Solutions' Asante Snap Insulin Pump
      • Medtronic's MiniMed Paradigm Revel Insulin Pump and Infusion Sets
        • Medtronic Paradigm Insulin Reservoir Recall
        • FDA Warning Letter
      • Sooil Development's Diabecare Insulin Pumps
      • Roche Insulin Pumps
        • Accu-Chek Combo BGM and Pump System
        • Accu-Chek Spirit
        • Accu-Check D-TRONplus
      • Tandem Diabetes Care's t:slim Insulin Delivery System
      • Insulin Delivery Patch Pumps
        • CeQur's PaQ Insulin Delivery Device
        • Cellnovo's Mobile Diabetes Management System
        • Insulet's OmniPod Insulin Management System
        • Valeritas' V-Go
    • Products in Development
      • Becton Dickinson-JDRF Micro-Needle Technology
      • Debiotech's JewelPUMP
      • Insulet's OmniPod for Humulin R U-500 Insulin
      • Roche's R&D Pipeline
        • Accu-Chek Insight and NovoRapid PumpCart
      • Johnson & Johnson's Calibra Wearable Insulin Patch
      • Tandem Diabetes Care's Pipeline
        • t:flex Insulin Pump
        • t:sensor Insulin Pump and CGM System
        • t:sport Insulin Delivery System
        • t:dual Infusion System
      • Ypsomed's New Insulin Pump
  • ALTERNATIVE INSULIN DELIVERY DEVICES
    • Generex Biotechnology's Oral-lyn
    • Insulin Inhalers
      • Development Considerations
        • MannKind's AFREZZA
        • Dance Pharmaceuticals' Adagio

INTEGRATED CGM-INSULIN PUMP SYSTEMS

  • CURRENTLY-AVAILABLE PRODUCTS
    • Medtronic's Integrated Diabetes Management Products
      • Clinical Trials
        • STAR Studies
      • REAL Trend Study
      • Animas Vibe
  • PRODUCTS IN DEVELOPMENT
    • Insulet's CGM-Enabled OmniPod
  • ARTIFICIAL PANCREAS TECHNOLOGY
    • SEMI-CLOSED-LOOP SYSTEMS
      • Medtronic's Low Glucose Suspend/Threshold Suspend Automation Technology
        • Paradigm Veo with Low Glucose Suspend
        • MiniMed 530G System
        • ASPIRE Study
          • ASPIRE In-Home
  • RESEARCH & DEVELOPMENT
    • FDA Artificial Pancreas Development Guidelines
    • Key Closed-Loop Development Projects
      • The Juvenile Diabetes Research Foundation's Artificial Pancreas Project
        • Real-World Artificial Pancreas Study
        • University of Cambridge Studies
        • UC Santa Barbara & Sansum Diabetes Research Institute
        • Massachusetts General Hospital and Boston University
        • JDRF-Helmsley Charitable Trust Sensor Initiative
        • Collaboration with BD
        • Collaboration with Medtronic
        • Collaboration with Tandem Diabetes Care
        • Collaboration with DexCom
        • Collaboration with Animas
      • Medtronic's Closed-Loop Diabetes Management System
        • Overnight Closed Loop Studies
      • Mayo Clinic
      • UC Santa Barbara, Sansum Diabetes Research Institute, Mayo Clinic, Universities of Virginia & Padova
      • AP@home Project
      • MD-Logic Artificial Pancreas System
        • DREAM Project
      • Rensselaer Polytechnic Institute
        • Clinical Studies

DIABETES DEVICE MANUFACTURERS

  • DIABETES DEVICE COMPANY DIRECTORY
    • Abbott Laboratories
      • FreeStyle Navigator II Continuous Glucose Monitoring System
      • Blood Glucose Monitors
        • FreeStyle Blood Glucose Monitors and Test Strips
        • Precision Xtra/Optium Xceed System
        • CoPilot Health Management System
        • Precision XceedPro and PrecisionWeb Professional Use Products
      • Alliance with Insulet
      • Litigation
        • DexCom
      • Financial Performance
        • Latest Results
    • Arkray
      • Blood Glucose Self-Testing
        • Glucocard Meters
        • Assure Products
      • Current Alliances and Contracts
        • MyCareTeam
        • A Menarini Diagnostics
    • Bayer
      • Blood Glucose Monitoring Systems
        • Contour Next Link
        • Contour Next and Contour Next USB
        • Contour USB
        • Contour, Contour TS, Contour Link and Breeze 2
      • Alliance with Medtronic
      • Financial Performance
    • Becton, Dickinson and Company
      • BD Diabetes Care Products
        • BD Ultra-Fine Nano 4mm Pen Needle with EasyFlow Technology
        • BD Ultra-Fine Nano Pen Needle
        • AutoShield Duo Pen Needle
      • Collaboration with the JDRF
      • Litigation with Insulet
      • Financial Performance
    • DexCom
      • SEVEN PLUS CGM System
      • DexCom G4 PLATINUM CGM
      • GlucoClear
      • Research and Development
        • DexCom Share System
        • Paediatric Use CGM in the US
      • SweetSpot Diabetes Care Acquisition
      • Current Alliances
        • Juvenile Diabetes Research Foundation
        • Tandem Diabetes Care
        • Edwards LifeSciences
        • Animas
      • Litigation with Abbott
      • Financial Performance
        • Latest Results and Outlook
    • Insulet
      • OmniPod Insulin Management System
      • Research and Development
      • Current Alliances
        • Eli Lilly and Company
        • LifeScan
        • Abbott
        • Ypsomed
        • GlaxoSmithKline
        • Flextronics International
      • Acquisition of Neighborhood Diabetes
      • Litigation
        • Medtronic
        • Rydex Technologies
        • Becton, Dickinson and Company
      • Financial Performance
        • Latest Results and Outlook
    • Johnson & Johnson
      • Animas Operations
        • Animas Products
        • Current Alliances
        • Litigation with Medtronic
      • Calibra Medical Operations
      • LifeScan Operations
        • Consumer Blood Glucose Monitoring Products
        • Current Alliances
        • Litigation
      • Financial Performance
    • Medtronic
      • Enlite CGM Sensor
      • Integrated Diabetes Management Products
        • Paradigm Veo with Low Glucose Suspend
        • MiniMed 530G System
        • MiniMed Paradigm REAL-Time Revel
        • MiniMed Paradigm Revel Insulin Pump and Infusion Sets
      • Medtronic Paradigm Insulin Reservoir Recall
        • FDA Warning Letter
      • Guardian REAL-Time CGM System
      • Professional Use CGM Products
        • Sentrino CGM System
        • iPro 2 Professional
      • CareLink Software
      • Bayer Contour Link and Contour Next Link Blood Glucose Meters
      • Research and Development
        • Closed-Loop Diabetes Management System
      • Key Alliances
        • National Institute of Hospital Administration, China
        • Bayer
      • Litigation
        • Insulet
        • Animas
      • Financial Performance
    • Nipro Diagnostics
      • Blood Glucose Monitoring Products
      • Blood Glucose Monitors
        • TRUE2go and TRUEresult
        • TRUEread
        • TRUEbalance
        • TRUEtrack
        • TRUEmanager Diabetes Management Software
      • Alliance with NextGen Healthcare Information Systems
    • Roche Diabetes Care
      • Diabetes Care Products
        • Blood Glucose Monitoring Products
        • Accu-Chek Aviva Expert
        • Accu-Chek FastClix Lancing Device
      • Accu-Chek Combo BGM and Pump System
      • Insulin Pumps
        • Accu-Chek Spirit
        • Accu-Check D-TRONplus
      • Data Management Tools
      • Research & Development
        • Accu-Chek Insight and NovoRapid PumpCart
        • SOLO Micropump
      • Current Alliances
        • Novo Nordisk
        • InterComponentWare
      • Litigation with LifeScan
      • Financial Performance
        • Latest Results
    • Ypsomed
      • mylife Diabetes Care Products
        • mylife Unio BGM
        • mylife Pura BGM
      • Ypsomed Delivery Systems
      • Acquisition of ICU Medical's Orbit Infusion Set Business
      • In Development: New Insulin Pump
      • Current Alliances
        • Tonghua Dongbao Pharmaceutical Co Ltd
        • Lifescan
        • Insulution AB
        • B Braun
        • Distribution Agreements
        • Insulet
        • Bionime
      • Financial Performance

APPENDICES

  • LIST OF ABBREVIATIONS
  • REPORT METHODOLOGY

List of Tables

  • Diabetes Prevalence for the Top 10 Countries, 2011-2030 (million)
  • Global Diabetes Market by Product Type, 2006-2012 (US$ million)
  • Global Diabetes Market Growth Rates by Product Type, 2006-2011 (%)
  • Key Companies' Diabetes Care Sales, 2005-2012 (US$ million)
  • Non-US Companies' Diabetes Sales in Reported Currency, 2006-2012 (million)
  • Leading Companies' International Diabetes Care Sales, 2006-2012 (US$ million)
  • Key Companies' US Diabetes Care Sales, 2006-2012 (US$ million)
  • Key Companies: Market Presence & Position by Product Area, 2012
  • Key Companies: Current & Future Potential Market Presence by Product Area
  • Global Diabetes Market Forecast by Product Type, 2012-2018E (US$ million)
  • Global Diabetes Market Forecast Growth Rates by Product, 2012-2018E (%)
  • Overview: Glucose Monitoring Products
  • Public Companies' Glucose Monitoring Sales, 2006-2012 (US$ million)
  • SMBG Market by Major Geographic Region, 2011-2012 (US$ million)
  • Summary: SMBG Growth Drivers, Restraints & Opportunities
  • Key Companies' SMBG Sales, 2006-2012 (US$ million)
  • Competing Self-Testing Blood Glucose Monitoring Products
  • Summary: CGM Benefits, Challenges & Opportunities
  • Companies' CGM Sales, 2006-2012 (US$ million)
  • Insulin Delivery Market by Product Type 2005-2012 (US$ million)
  • Key Companies' Insulin Delivery Sales, 2006-2012 (US$ million)
  • Summary: Insulin Delivery Market Growth Drivers, Restraints & Opportunities
  • Insulin Delivery Market Forecast by Product Type 2012-2018E (US$ million)
  • Insulin Pump Market: Growth Drivers, Restraints & Opportunities
  • Key Companies' Insulin Pump Sales, 2006-2012 (US$ million)
  • Recent Key Events
  • Abbott Diabetes Care Sales by Region, 2007-2012 (US$ million)
  • Recent Key Events
  • Recent Key Events
  • Bayer Diabetes Care Revenue, 2008-2012 (EUR million)
  • Recent Key Events
  • BD Diabetes Care Sales by Region, 2008-2012 (US$ million)
  • Recent Key Events
  • DexCom - Operating Results, 2008-2012 (US$ million)
  • Recent Key Events
  • Insulet - Operating Results, 2008-2012 (US$ thousands)
  • Recent Key Events
  • J&J Diabetes Care Revenue, 2007-2012 (US$ million)
  • Recent Key Events
  • Medtronic - Diabetes Sales by Region, Fiscal 2008-2013 (US$ million)
  • Recent Key Events
  • Recent Key Events
  • Roche Diabetes Care Sales by Region, 2011-2012 (SFr million)
  • Recent Key Events
  • Ypsomed - Operating Results, Y/E 31st March 2011-2013 (SFr millions)
  • Ypsomed - Results by Business Segment, Y/E 31st March 2011-2013 (SFr millions)
  • Ypsomed - Revenue by Geographic Region, Y/E 31st March 2011-2013 (SFr millions)

List of Charts

  • Fig.1: Diabetes Prevalence by Geographic Region, 2011-2030
  • Fig.2: Diabetes Device Market by Major Product Category, 2012
  • Fig.3: Percentage of US Diabetes Patients by Treatment Type, 2007-2009
  • Fig.4: Diabetes Device Market by Product Type, 2012
  • Fig.5: Global Diabetes Device Market, 2005-2012 (US$ billion)
  • Fig.6: Global Diabetes Market By Product Type, 2006-2012 (US$ billion)
  • Fig.7: Global Diabetes Device Market by Region, 2012
  • Fig.8: US Market by Product Type, 2012
  • Fig.9: International Market by Product Type, 2012
  • Fig.10: Diabetes Device Market Share by Company, 2012
  • Fig.11: Diabetes Device Market by Product, 2018E
  • Fig.12: Global Glucose Monitoring Market, 2005-2012 (US$ billion)
  • Fig.13: Global Glucose Monitoring Market Growth, 2005-2012 (%)
  • Fig.14: Glucose Monitoring Market by Product Type, 2012
  • Fig.15: Glucose Monitoring Market Share by Company, 2012
  • Fig.16: Global SMBG Market, 2005-2012 (US$ million)
  • Fig.17: Global SMBG Market Growth Rates, 2005-2012 (%)
  • Fig.18: SMBG Market by Product Type, 2012
  • Fig.19: SMBG Market by Region, 2012
  • Fig.20: Global SMBG Market, 2012-2018E (US$ billion)
  • Fig.21: Global SMBG Market Growth Rates, 2012-2018E (%)
  • Fig.22: SMBG Market Share by Company, 2012
  • Fig.23: United States SMBG Market Share by Company, 2012
  • Fig.24: SMBG International Market Share by Company, 2012
  • Fig.25: Global CGM Market, 2006-2012 (US$ million)
  • Fig.26: Percentage of CGM Sales Volumes by Hardware & Consumables, 2012
  • Fig.27: CGM Market by Region, 2012
  • Fig.28: Global CGM Market Forecast, 2012-2018E (US$ million)
  • Fig.29: Global CGM Market Growth Rates, 2012-2018E (%)
  • Fig.30: Global CGM Market Shares by Company, 2012
  • Fig.31: US CGM Market Shares by Company, 2012
  • Fig.32: International CGM Market Shares by Company, 2012
  • Fig.33: Percentage of US Diabetes Patients by Treatment Type, 2007-2009
  • Fig.34: Global Insulin Delivery Market, 2007-2012 (US$ billion)
  • Fig.35: Global Insulin Delivery Market Growth Rates, 2006-2012 (%)
  • Fig.36: Percentage of Insulin Delivery Market by Product Type, 2012
  • Fig.37: Global Insulin Delivery Market Estimated Growth Rates, 2012-2018E (%)
  • Fig.38: Estimated Insulin Delivery Market by Product Type, 2018E
  • Fig.39: Percentage of Novo Nordisk's Insulin Sold in Pens by Region, 2011-2012
  • Fig.40: Manual Insulin Delivery Market by Geographic Region, 2012
  • Fig.41: Global Insulin Pen Market: Disposable vs Reusable Pens, 2012
  • Fig.42: Global Insulin Pump Market, 2005-2012 (US$ million)
  • Fig.43: Global Insulin Pump Market Growth Rates, 2006-2012 (%)
  • Fig.44: Insulin Pump Market by Product, 2012
  • Fig.45: Insulin Pump Market by Region, 2012
  • Fig.46: Insulin Pump Adoption Rates for Type 1 Diabetes Patients by Key Country, 2010
  • Fig.47: Insulin Pump Market Shares, 2012
  • Fig.48: Global Insulin Pump Market Forecast, 2012-2018E (US$ million)
  • Fig.49: Global Insulin Pump Market Estimated Growth Rates, 2012-2018E (%)
  • Fig.50: Percentage of Abbott Diabetes Care Revenue by Region, 2012
  • Fig.51: Percentage of BD Diabetes Care's Revenue by Region, 2012
  • Fig.52: J&J Diabetes Care Sales by Region, 2012
  • Fig.53: J&J Diabetes Care Sales, 2004-2012 (US$ million)
  • Fig.54: Medtronic Diabetes Revenue, Fiscal 2005-2013 (US$ million)
  • Fig.55: Medtronic Diabetes Revenue by Region, Fiscal 2013
  • Fig.56: Roche Diabetes Care - Revenue by Product Line, 2012
  • Fig.57: Roche Diabetes Care - Revenue by Region, 2012
  • Fig.58: Ypsomed - Revenue by Business Segment, Fiscal 2012/13
  • Fig.59: Ypsomed - Revenue by Geographic Location, Fiscal 2012/13
Back to Top